Mantis Biotechnology Corp — Form D

Mantis Biotechnology Corp of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-03. The offering totals $5.5M, of which $4.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-12-03
• Form: D
• Accession: 0002099347-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.5M
• Amount sold: $4.8M
• Remaining: $675K
• Investors: 5
• Date of first sale: 2025-11-17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-565671

Issuer

• Name: Mantis Biotechnology Corp
• CIK: 0002099347
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 576 EUREKA STREET, SAN FRANCISCO, CA, 94114
• Phone: (970) 779-1386

Officers, directors & promoters (4)

More

• CIK 2099347 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search